BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 18, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PLX4032: Phase III started

Roche began the open-label, international Phase III BRIM3 trial comparing oral RG7204 to dacarbazine in about 700 previously untreated patients. The trial start triggers an undisclosed milestone payment...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >